Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment

Area of Science:

• Neuroscience
• Pharmacology
• Addiction Medicine

Background:

• Dopamine system deficiencies are linked to behavioral issues in stimulant use disorders.
• Similarities and differences in dopamine dysfunction between cocaine and methamphetamine use disorder may affect treatment.
• Current treatments for stimulant use disorders face significant challenges.

Purpose of the Study:

• To compare the epidemiology of cocaine and methamphetamine use disorder.
• To detail the pharmacokinetic and pharmacodynamic properties of cocaine and methamphetamine, focusing on dopamine system effects.
• To review treatment outcomes and explore the trace amine-associated receptor (TAAR) as a therapeutic target.

Main Methods:

• Literature review comparing epidemiological data.
• Analysis of pharmacokinetic and pharmacodynamic properties related to dopamine signaling.
• Synthesis of findings from pharmacological clinical trials and TAAR research.

Main Results:

• Identified shared and distinct epidemiological patterns for cocaine and methamphetamine use disorder.
• Detailed the specific impacts of each drug on dopamine pathways and signaling.
• Summarized clinical trial results and highlighted TAAR's role in dopamine dysfunction.

Conclusions:

• Dopamine system dysregulation is central to stimulant use disorders, with drug-specific nuances.
• Understanding these differences is crucial for developing effective pharmacological treatments.
• Targeting the trace amine-associated receptor presents a promising avenue for future therapeutic interventions.